MG-63 Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Basic details about MG-63 cells
| Description | MG-63 cells, a human osteosarcoma cell line derived from the bone of a 14-year-old White male patient with osteosarcoma, are a pivotal model in bone biology research. MG63 human osteosarcoma cells, with their fibroblast morphology and rapid proliferation, serve as an essential tool in understanding bone metabolism, particularly in the context of osteosarcoma. MG-63 cells produce high levels of human interferon when induced with agents like polyinosinic acid-polycytidylic acid, cycloheximide, and actinomycin D. Enhanced interferon production is crucial for studies focusing on the immune responses within the bone microenvironment. Seeding MG-63 cells on biocompatible surfaces like Bioglass disks, titanium (Ti-6Al-4V) disks, and cobalt chrome (Co-Cr-Mo) alloys is possible due to their strong cell adherence and attachment. They are a good osteoblastic model for studying osseointegration and bone cell-implant interactions with amorphous carbon films and composite tantalum. Research involving the osteoblastic cell line MG-63 often focuses on apoptosis, the regulation, and expression of osteocalcin, and the impact of adenosine on bone metabolism. Overall, MG-63 cells remain a cornerstone in the study of human osteoblast-like cells, offering insights into cell growth, differentiation, and the intricate interactions between bone cells and their microenvironment. |
|---|---|
| Organism | Human |
| Tissue | Bone |
| Disease | Osteosarcoma |
| Metastatic site | Bone, left femur |
| Synonyms | M-G63, MG63 |
Aspects of the human osteosarcoma cell line MG-63
| Age | 14 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Morphology | Fibroblast-like |
| Growth properties | Adherent |
Specifications
| Citation | MG-63 (Cytion catalog number 300441) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0426 |
Genomics of MG63 cells
| Receptors expressed | Transforming growth factor beta (TGF beta, type I and type II) |
|---|---|
| Products | Interferon |
Handling
| Culture Medium | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 x 104 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 48 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Genetic profile
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300441-140725 | Certificate of Analysis | 18. Aug. 2025 | 300441 |
| 300441-140922 | Certificate of Analysis | 23. May. 2025 | 300441 |